A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

NCT02759250 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx